Suchergebnisse - "Zhang, Li"

PubPharm (14)

1

De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients

enthalten in: Transplant infectious disease : an official journal of the Transplantation Society | 2022

von Simons, L. | Ozer, E. | Gambut, S. | +10

2

Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19

enthalten in: Clinical immunology (Orlando, Fla.) | 2022

von Yong, Y. | Zhang, L. | Hu, Y. | +12

3

De Novo design of potential inhibitors against SARS-CoV-2 Mpro

enthalten in: Computers in biology and medicine | 2022

von Li, S. | Wang, L. | Meng, J. | +3

4

Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening

enthalten in: Future medicinal chemistry | 2022

von Zhang, L. | Zhao, H. | Liu, J. | +3

5

A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Li, C. | Noreen, S. | Zhang, L. | +9

6

A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region

enthalten in: Frontiers in public health | 2022

von Wang, J. | Zhang, S. | Na, J. | +7

7

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19 : a randomised clinical trial

enthalten in: Annals of medicine | 2021

von Li, C. | Luo, F. | Liu, C. | +24

8

Biological activity-based modeling identifies antiviral leads against SARS-CoV-2

enthalten in: Nature biotechnology | 2021

von Huang, R. | Xu, M. | Zhu, H. | +17

UpdateOf: bioRxiv. 2020 Jul 27;:. - PMID 32766591

9

Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation

enthalten in: Bioorganic chemistry | 2021

von Guo, S. | Xie, H. | Lei, Y. | +4

10

Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development

enthalten in: Signal transduction and targeted therapy | 2021

von Zhao, M. | Yang, W. | Yang, F. | +8